Table 12.21 Effects of Methotrimeprazine on Agitation Post ABI
Author Year Country Research Design PEDro Sample Size |
Methods | Outcomes |
Maryniak et al. (2001) Canada Case Series N=120 |
Population: TBI=95, ABI=25; Mean Age=37.8 yr; Gender: Male=89, Female=31. Intervention: Retrospective review of patients attending an inpatient ABI rehabilitation unit. Patients administered methotrimeprazine (MTZ) were analyzed. Outcome Measure: Agitated Behaviour Scale. |
1. 58% had agitation but 56 patients were treated with MTZ (10-25 mg, 4×/day) with a mean length of treatment of 41.9 day. 2. MTZ, for the most part (96% of patients), was both safe and effective for controlling agitation. |